Traditionally, drug discovery focused on enzymatic reactions and receptor-based signaling in the body.The majority of proteins without well-defined binding pockets were considered undruggable.Protein-Protein Interaction (PPI) modulators have changed the game by stabilizing interactions between proteins.The case of the HER2 receptor demonstrates that undruggable targets can be tackled with the right biological strategy.